Core Viewpoint - Acadia Healthcare Company, Inc. has received a consensus recommendation of "Hold" from analysts, with a mixed rating distribution and an average price target of $21.15 [2] Analyst Ratings - Mizuho reduced its price target from $22.00 to $17.00 and maintained a "neutral" rating [3] - Bank of America downgraded its rating from "neutral" to "underperform" and lowered the target price from $21.50 to $13.00 [3] - Guggenheim decreased its target price from $27.00 to $22.00 while maintaining a "buy" rating [3] - Zacks Research upgraded the rating from "strong sell" to "hold" [3] - Cantor Fitzgerald set a price objective of $17.00 [3] Institutional Holdings - Wellington Management Group increased its stake by 24.9%, owning 11,774,308 shares valued at $167.08 million after acquiring 2,350,760 shares [4][5] - Vanguard Group raised its position by 7.8%, now holding 9,417,045 shares worth $233.17 million after an additional purchase of 681,278 shares [4][5] - Goldman Sachs Group increased its holdings by 417.8%, owning 4,728,613 shares valued at $67.10 million after buying 3,815,471 shares [4][5] - Abrams Bison Investments raised its position by 22.3%, now owning 4,380,000 shares worth $108.45 million after purchasing 800,000 shares [4][5] - UBS Group increased its stake by 8.8%, now holding 4,336,698 shares valued at $107.38 million after acquiring 350,484 shares [4][5] Financial Performance - Acadia Healthcare reported an EPS of $0.07 for the last quarter, exceeding the consensus estimate of $0.03 by $0.04 [7] - The company generated revenue of $821.46 million, surpassing the consensus estimate of $800.10 million, with a year-over-year revenue increase of 6.1% [7] - The company has set FY 2026 EPS guidance at 1.300-1.550 and Q1 2026 guidance at 0.250-0.300 [7] Company Overview - Acadia Healthcare, founded in 2005 and headquartered in Franklin, Tennessee, specializes in behavioral healthcare services, focusing on mental health and addiction treatment across the U.S. [8] - The company operates a diversified network that includes inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and intensive outpatient programs [9]

Company Overview - Acadia Healthcare Company, Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the United States, operating in various settings such as inpatient mental hospitals, specialty treatment facilities, residential treatment programs, and outpatient clinics [4]. Financial Performance - For the fourth quarter of 2025, Acadia reported revenue of $821.5 million, reflecting a 6.1% increase compared to the previous year. Same-facility revenue rose by 4.4%, driven by a 3.1% increase in patient days and a 1.3% rise in revenue per day [3]. - The company experienced a net loss of $13.02 per diluted share, which included a non-cash goodwill impairment charge of $996.2 million. However, adjusted net income was reported at $6.1 million, or $0.07 per share [3]. - Adjusted EBITDA for the quarter was $99.8 million, with a $52.7 million adjustment to professional and general liability reserves [3]. - Acadia increased its licensed beds by 181 in the quarter and by 1,089 throughout 2025. Revenue is projected to range from $3.37 billion to $3.45 billion in 2026, with adjusted EPS expected to be between $1.30 and $1.55 [3]. Analyst Ratings - On March 2, 2026, Barclays analyst Andrew Mok raised Acadia's price target to $20 from $14 while maintaining an Equal Weight rating [2][7]. - Acadia Healthcare was recognized as one of the 12 Best Performing Stocks in February [1].

Core Insights - Acadia Healthcare is focusing on leadership accountability and organizational structure improvements under CEO Debbie Osteen, aiming to enhance decision-making processes and operational efficiency [1][2][3] Management Focus Areas - The management is prioritizing the right personnel in key roles and clearer accountability, particularly regarding new and joint venture facilities [1] - There is enthusiasm within the organization following Osteen's return as CEO, with a focus on leveraging existing bed capacity for growth without significant new capital investment [2][3] Financial Performance and Projections - Professional liability costs have significantly increased, with PLGL expenses rising by $61 million in 2025 and claims up 186%, leading to a focus on debt reduction and lower capital expenditures in 2026 [4][17] - Acadia is facing payer headwinds, particularly a conservative estimate of $25–$30 million impact from New York Medicaid, with plans to mitigate this through backfilling in New Jersey and Pennsylvania [5][14][15] Capacity and Facility Management - The company aims to ramp up and fill approximately 3,000 newly added beds from 2023 to 2026, with guidance for an additional 400–600 beds, focusing on expanding existing facilities rather than new builds [6][12] - Management believes it has largely completed recent facility closures and is now focused on improving operations and occupancy rates [8] Startup Dynamics and Facility Performance - Young discussed the performance of new facilities, attributing underperformance to overly aggressive expectations and delays in licensure processes [7] - Acadia has several large facilities coming online, with guidance assumptions based on recent history to ensure realistic projections [9][11] Liability and Payer Environment - The company has seen a significant increase in professional liability expenses, with reserves rising to $155 million, and is actively monitoring claims and settlements [16][18] - Managed Medicaid trends are expected to remain stable, with a focus on documentation and advocacy to support payer negotiations [19] Capital Allocation Strategy - Acadia's leverage is approximately 4x, with a priority on debt paydown over share repurchases, and planned capital expenditures are expected to decline significantly in 2026 [20][21]

Company Overview - Acadia Healthcare operates one of the largest networks of behavioral healthcare facilities in the United States, offering a diversified portfolio of inpatient and outpatient services [5] - The company generates revenue primarily from patient care services, focusing on mental health and addiction treatment across a network of owned and operated facilities [7] - Revenue for the trailing twelve months (TTM) is reported at $3.27 billion, with a net income of $107.36 million [4] Recent Developments - Canyon Capital Advisors sold all 521,774 shares of Acadia Healthcare in the fourth quarter, resulting in a decrease of approximately $12.92 million in the quarter-end position value [2][6] - Acadia Healthcare's shares have declined about 20% over the past year, with a significant drop of up to 60% in recent months due to broader financial pressures [6] - The company's revenue rose 6.1% in the fourth quarter to $821.5 million and 5% for the year to $3.31 billion, with same facility revenue climbing 4.4% [6] Financial Performance - Adjusted EBITDA fell to $608.9 million for the year, and the quarter included a $996.2 million goodwill impairment tied to facility closures and write-downs [8] - Net leverage is reported at 4.0x adjusted EBITDA, indicating limited room for operational missteps [8] Market Position and Investor Sentiment - The broader portfolio of Canyon Capital Advisors leans heavily into distressed real estate and cyclical energy, while Acadia Healthcare offers exposure to a structurally growing mental health market [9] - Long-term investors are advised to monitor occupancy trends and liability reserve stability, as well as the potential for margin stabilization and lower leverage trends [10]

Core Viewpoint - Engine Capital Management has significantly reduced its stake in Acadia Healthcare, indicating potential concerns about the company's performance and market confidence [2][7]. Company Overview - Acadia Healthcare operates a large network of behavioral health facilities, focusing on mental health and addiction treatment across the U.S. and Puerto Rico [5][8]. - The company reported a total revenue of $3.27 billion and a net income of $107.36 million for the trailing twelve months (TTM) [4]. Recent Transaction Details - On February 17, 2026, Engine Capital Management sold 2,256,741 shares of Acadia Healthcare, valued at approximately $42.70 million based on the average closing price in Q4 2025 [1][2]. - Following this transaction, the value of Acadia Healthcare's stake decreased by $59.35 million, reflecting both trading activity and price changes [2]. Stock Performance - As of February 17, 2026, Acadia Healthcare's shares were priced at $16.42, representing a 60.04% decline over the past year, significantly underperforming compared to the S&P 500's approximate 13% gain during the same period [7][4]. Future Outlook - Acadia Healthcare reaffirmed its 2025 guidance, projecting revenue between $3.28 billion and $3.30 billion, adjusted EBITDA of $601 million to $611 million, and adjusted EPS of $1.94 to $2.04 [10]. - The company operates 278 facilities with around 12,500 beds, indicating a strong operational scale in the behavioral health sector [10]. Leadership and Market Challenges - Recent leadership changes, including the return of Debbie Osteen as CEO, add uncertainty as the board seeks to enhance shareholder value [11]. - The company faces challenges from Medicaid financing changes and broader macroeconomic pressures, which may impact its operational stability [11].

Core Viewpoint - Acadia Healthcare Company, Inc. will participate in multiple investor conferences in March 2026, showcasing its position as a leading provider of behavioral healthcare services in the U.S. [1] Group 1: Investor Conferences - The company will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference from March 1-4, 2026, with a presentation on March 2 at 11:35 a.m. ET [1] - Acadia will also attend the Leerink Partners 2026 Global Healthcare Conference from March 9-12, 2026, presenting on March 9 at 3:40 p.m. ET [1] - Additionally, the company will be part of the Barclays 28th Annual Global Healthcare Conference from March 10-12, 2026, with a presentation scheduled for March 10 at 12:00 p.m. ET [1] Group 2: Company Overview - As of September 30, 2025, Acadia operates 278 behavioral healthcare facilities with approximately 12,500 beds across 40 states and Puerto Rico [1] - The company employs around 25,500 staff and serves over 82,000 patients daily, making it the largest stand-alone behavioral healthcare company in the U.S. [1] - Acadia provides a range of behavioral healthcare services in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [1]

Group 1 - Acadia Healthcare Company Inc. (NASDAQ:ACHC) is considered a promising stock under $50, with Mizuho lowering its price target to $17 from $22 while maintaining a Neutral rating [1] - Mizuho identified 2026 as a pivotal year for the managed care and health facilities sector, suggesting recovery in margins across Commercial, Medicaid, and Medicare after a 3-year downturn [1] - Barclays analyst Andrew Mok reduced Acadia's price target to $14 from $17 following the company's third guidance cut of the year due to a $49 million increase in legal costs [2] Group 2 - RBC Capital adjusted its price target for Acadia Healthcare to $19 from $22, expressing disappointment over another reduction in financial guidance related to underestimated liability expenses [3] - Management at Acadia expects high professional and general liability costs to persist through 2026 [3] - Acadia Healthcare provides behavioral healthcare services in the US and Puerto Rico, but certain AI stocks are noted to offer greater upside potential with less downside risk [4]

Market Overview - The market is broadening beyond technology, with materials, defense, transports, and airlines showing strong setups as 2026 begins, while technology, particularly software, is lagging [1] - The start of 2026 is characterized as 'very' bullish due to increased market participation and breakout performances in certain sectors [1] Sector Analysis - The energy sector is identified as a 'fake out' with stocks hitting resistance levels and pulling back, suggesting caution before investing [2] - The materials sector is highlighted as a breakout from a year-long base, supported by silver, gold, and packaging stocks, indicating potential for further gains [2] - The defense sector is noted for a significant breakout, suggesting strong performance ahead [2] Small-Cap Stocks Outlook - The Russell 2000 has reached all-time highs and is on track for its eighth consecutive month of gains, creating a positive backdrop for small-cap stocks in 2026 [3] - Small-cap companies are economically sensitive and benefit from lower interest rates, but only about 1% of active long managers have been beating their benchmarks over the last 18 months [3] - Despite quality small-cap stocks underperforming, the long-term earnings growth setup for small caps is more favorable compared to mid-cap, large-cap, or MAG7 stocks [3] Stock Recommendations - A list of 10 promising stocks under $50 has been compiled based on high upside potential and popularity among hedge funds [6] - The strategy of imitating top stock picks from elite hedge funds has shown significant outperformance, with a return of 427.7% since May 2014 [7] Company Highlights - **Acadia Healthcare Company Inc. (NASDAQ:ACHC)**: Current share price is $13.67 with an average upside potential of 42.54%. The company is emerging from a 3-year downturn in underwriting, with expectations for margin recovery in managed care [9][10] - **Cipher Mining Inc. (NASDAQ:CIFR)**: Current share price is $16.90 with an average upside potential of 62.21%. The company has acquired a new 200-megawatt site in Ohio, diversifying its geographical footprint and enhancing its development pipeline to 3.4 gigawatts across 8 sites [13][14][15]

Core Viewpoint - Acadia Healthcare Company, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 12-15, 2026, in San Francisco, California [1]. Group 1: Company Participation - The company will have an online webcast of its presentation available on its website starting at 5:15 p.m. Pacific Time on January 13, 2026 [1][2]. - A replay of the presentation will be accessible on the company's website for 30 days following the event [2]. Group 2: Company Overview - Acadia is a leading provider of behavioral healthcare services in the U.S., operating a network of 278 facilities with approximately 12,500 beds across 40 states and Puerto Rico as of September 30, 2025 [3]. - The company employs around 25,500 staff members and serves over 82,000 patients daily, making it the largest stand-alone behavioral healthcare company in the U.S. [3]. - Acadia offers a range of behavioral healthcare services in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [3].

Core Insights - Engine Capital Management has initiated a new position in Acadia Healthcare, acquiring 2.6 million shares valued at $64 million, indicating a strategic investment in the behavioral health sector during a period of transition for the company [1][2]. Company Overview - Acadia Healthcare is a leading provider of behavioral healthcare services, operating hundreds of facilities across the U.S. and Puerto Rico, focusing on inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [5][7]. - The company reported a total revenue of $3.3 billion and a net income of $107.4 million, with a market capitalization of $1.4 billion [4]. Financial Performance - Acadia Healthcare experienced a year-over-year revenue growth of 4.4%, reaching $851.6 million, alongside a 3.3% increase in same-facility admissions [9]. - However, the company has lowered its full-year revenue, EBITDA, and EPS guidance due to payor scrutiny, Medicaid softness, and increased liability costs, with adjusted EBITDA falling to $173 million from $194 million a year earlier [9]. Investment Rationale - The new position by Engine Capital represents 7.6% of its reportable assets under management as of September 30, suggesting a significant commitment to Acadia Healthcare [3]. - The stock price of Acadia Healthcare has decreased by 63% over the past year, underperforming the S&P 500, which has increased by 13% during the same period [3]. - Management is taking steps to improve financial performance by cutting 2026 capital expenditures by at least $300 million and aiming for positive free cash flow, which could enhance returns as new bed additions contribute to revenue [10].